Related Experiment Video
Updated: Jun 23, 2026
26:48
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
18.0K
Outcome and Sequelae of Autoimmune Encephalitis
Kathryn A Kvam1, Jean-Paul Stahl2, Felicia C Chow3,4
1Department of Neurology & Neurological Sciences, Center for Academic Medicine, Stanford University, Stanford, CA, USA. kkvam@stanford.edu.
Journal of Clinical Neurology (Seoul, Korea)
|January 5, 2024
Summary
Autoimmune encephalitis survivors often experience lasting cognitive and psychiatric impairments, such as memory and attention deficits, depression, and anxiety, despite initial recovery. Further research and standardized assessments are crucial for understanding and managing these long-term outcomes.
Area of Science:
- Neurology
- Immunology
Background:
- Autoimmune encephalitis is an increasingly recognized neurological disorder with distinct clinical presentations.
- While acute phases are understood, long-term outcomes and persistent sequelae remain less explored.
Purpose of the Study:
- To review and synthesize published literature on outcomes and sequelae following autoimmune encephalitis.
- To identify common deficits and evaluate the extent of recovery in affected patients.
Main Methods:
- A comprehensive literature search was conducted on PubMed for studies reporting outcomes after autoimmune encephalitis.
- Included studies assessed validated, quantitative outcomes, performing a narrative review of 146 relevant reports.
Main Results:
- Mortality rates ranged from 6%-19%, with relapse risks between 10%-62%.
- While many patients achieved good functional status (modified Rankin Scale ≤2), detailed assessments revealed frequent persistent cognitive impairments (memory, attention), psychiatric issues (depression, anxiety), and neurological deficits.
- Improvement in sequelae was observed over months to years post-discharge.
Conclusions:
- Autoimmune encephalitis frequently leads to lasting impairments in survivors, impacting cognitive, psychiatric, and global function.
- Standardized outcome evaluation protocols are essential for comparative research, rehabilitation planning, and guiding future treatment trials.
Related Concept Videos
01:25Arboviral Encephalitis
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:26Brain Abscess l: Introduction
A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...